The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

U.S. Rep. Alexandria Ocasio-Cortez (D-NY), whose district includes parts of the Bronx and Queens, is leading a congressional ...

In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...

The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in federal privacy legislation that would ...

With genetic testing company 23andMe filing for Chapter 11 bankruptcy ... lawfully acquired and held by a tech company has almost no federal regulation to begin with. Not only does the United ...

After the company’s bankruptcy filing in March, several congressional committees and federal agencies ... the heightened scrutiny, Regeneron said it will uphold 23andMe’s existing privacy ...

April 22 (Reuters) - Bankrupt genetic test company 23andMe may face opposition from the U.S. government if it tries to sell itself to a foreign buyer, according to a Tuesday court filing by ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

That material, and the genetic data it produced, was 23andMe’s most valuable asset. The company has said any buyer must comply with current privacy protections and federal regulations.